Vir Biotechnology, Inc. VIR Gain on retained interest in Sandisk
Gain on retained interest in Sandisk at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s gain on retained interest in sandisk.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s gain on retained interest in sandisk?
- Vir Biotechnology, Inc. (VIR) reported gain on retained interest in sandisk of -$170K in Q1 2026.
- How has Vir Biotechnology, Inc.'s gain on retained interest in sandisk changed year-over-year?
- Vir Biotechnology, Inc.'s gain on retained interest in sandisk decreased by 102.7% year-over-year, from $6.38M to -$170K.
- What is the long-term trend for Vir Biotechnology, Inc.'s gain on retained interest in sandisk?
- Over 2 years (2022 to 2024), Vir Biotechnology, Inc.'s gain on retained interest in sandisk has grown at a -78.5% compound annual growth rate (CAGR), from -$120.02M to -$5.53M.
- What does gain on retained interest in sandisk mean?
- This metric reflects the unrealized gains or losses resulting from changes in the fair value of equity investments held by the company. It captures the impact of market fluctuations on the company's investment portfolio, which is distinct from core operational performance. Investors use this to assess the volatility and financial impact of non-operating investment activities on the bottom line.